BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31230044)

  • 1. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
    Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
    Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of BRG1 (
    Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
    Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review.
    Duan H; Gao W; Wang L; Cao F; Teng L
    Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
    Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
    Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.
    Kilic AI; Mirza K; Mehrotra S; Pambuccian SE
    Diagn Cytopathol; 2019 Jul; 47(7):725-732. PubMed ID: 30897306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
    Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R
    Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
    Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
    Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF-deficient thoraco-pulmonary neoplasms.
    Sesboue C; Le Loarer F
    Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
    Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
    Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
    Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
    J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Report of a Bilateral Case in a Teenager Associated with SMARCA4 Germline Mutation.
    Lavrut PM; Le Loarer F; Normand C; Grosos C; Dubois R; Buenerd A; Conter C; Dijoud F; Blay JY; Collardeau-Frachon S
    Pediatr Dev Pathol; 2016; 19(1):56-60. PubMed ID: 26230154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features.
    Sun T; Gilani SM; Podany P; Harigopal M; Zhong M; Wang H
    Cancer Cytopathol; 2022 Aug; 130(8):620-629. PubMed ID: 35468657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
    Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
    Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.